Lori A. Worley

发表

Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death

Justis P. Ehlers, J. Harbour, M. Onken, 2004, Cancer Research.

An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.

J. Harbour, M. Onken, Lori A Worley, 2010, The Journal of molecular diagnostics : JMD.

Gene expressing profiling of iris melanomas.

David J. Wilson, L. Worley, J. Harbour, 2013, Ophthalmology.

Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

A. Bowcock, C. Helms, S. Duan, 2010, Science.

Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer

Jonathan B. Mitchem, D. Link, D. Sanford, 2014, Cancer Immunology, Immunotherapy.

Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

Jonathan B. Mitchem, T. Eberlein, A. Deshpande, 2013, Clinical Cancer Research.

Cancer Therapy : Preclinical In fl ammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer : A Role for Targeting the CCL 2 / CCR 2 Axis

Jonathan B. Mitchem, T. Eberlein, A. Deshpande, 2013 .

Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling

J. Harbour, M. Onken, Lori A. Worley, 2008, Melanoma research.

Integrative Genomic Analysis of Aneuploidy in Uveal Melanoma

J. Harbour, M. Onken, J. Ehlers, 2008, Clinical Cancer Research.

Association between Gene Expression Profile, Proliferation and Metastasis in Uveal Melanoma

L. Worley, J. Harbour, M. Onken, 2010, Current eye research.

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.

Kathryn J Fowler, M. Yano, A. Lockhart, 2016, The Lancet. Oncology.

Loss of Rb-E2F Repression Results in Caspase-8-mediated Apoptosis through Inactivation of Focal Adhesion Kinase*

J. Harbour, Lori A. Worley, J. Lieman, 2005, Journal of Biological Chemistry.

Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis

J. Harbour, M. Onken, Lori A. Worley, 2008, Melanoma research.

DDEF1 Is Located in an Amplified Region of Chromosome 8q and Is Overexpressed in Uveal Melanoma

Justis P. Ehlers, J. Harbour, M. Onken, 2005, Clinical Cancer Research.

Oncogenic mutations in GNAQ occur early in uveal melanoma.

M Laurin Council, A. Bowcock, S. Duan, 2008, Investigative ophthalmology & visual science.

A Metastasis Modifier Locus on Human Chromosome 8p in Uveal Melanoma Identified by Integrative Genomic Analysis

J. Harbour, M. Onken, Lori A. Worley, 2008, Clinical Cancer Research.

Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.

Young Sun, B. Tran, L. Worley, 2005, Investigative ophthalmology & visual science.

Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma

A. Bowcock, L. Worley, J. Harbour, 2013, Nature Genetics.

Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens.

J. Harbour, D. Char, M. Onken, 2006, The Journal of molecular diagnostics : JMD.

Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.

Justis P. Ehlers, Justis P Ehlers, J. Harbour, 2006, Cancer research.

Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.

David J. Wilson, B. Gallie, MORTON E. Smith, 2012, Ophthalmology.

Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal Melanoma

Arie Perry, L. Worley, J. Harbour, 2007, Clinical Cancer Research.

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma

A. Bowcock, J. Harbour, M. Onken, 2013, BMC Cancer.

Loss of Heterozygosity of Chromosome 3 Detected with Single Nucleotide Polymorphisms Is Superior to Monosomy 3 for Predicting Metastasis in Uveal Melanoma

A. Bowcock, L. Worley, J. Harbour, 2007, Clinical Cancer Research.

Tumor-induced STAT 3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer

Jonathan B. Mitchem, D. Link, D. Sanford, 2015 .

Altered expression of Rb and p53 in uveal melanomas following plaque radiotherapy.

L. Worley, J. Harbour, M. Brantley, 2002, American journal of ophthalmology.

Transducible peptide therapy for uveal melanoma and retinoblastoma.

L. Worley, J. Harbour, D. Ma, 2002, Archives of ophthalmology.

Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas.

R. Folberg, L. Worley, J. Harbour, 2005, American journal of ophthalmology.

Loss of Heterozygosity of Chromosome 3 Detected with Single Nucleotide Polymorphisms Is Superior to Monosomy 3 for PredictingMetastasis in Uveal Melanoma

A. Bowcock, J. Harbour, D. Char, 2007 .

Number 1 : Prospective Validation of a MultiGene Prognostic Assay in Uveal Melanoma

B. Gallie, T. Aaberg, J. Harbour, 2012 .

Integrative Genomic Analysis of Aneuploidy in Uveal Melanoma

Justis P. Ehlers, M. Onken, J. Ehlers, 2008, Clinical Cancer Research.

Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

A. Bowcock, C. Helms, J. Harbour, 2010, Science.

An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.

J. Harbour, M. Onken, Lori A. Worley, 2010, The Journal of molecular diagnostics : JMD.

Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.

Young Sun, B. Tran, R. Delston, 2005, Investigative ophthalmology & visual science.